QuantaLife, a US-based technology company for human genomics, has raised $17.2m in its series B round from a consortium including Mérieux Développement, the corporate venturing company of Institut Mérieux, a French industrial holding company. Venture capital firm Paladin Capital Group led the round, and was joined by peer Vital Financial, as well as Mérieux. Paladin… Continue reading Mérieux strikes QuantaLife deal
Category: Deals
SR One wraps itself in Semprus round
GSK’s SR One co-led with venture capital (VC) firm Foundation Medical Partners as new investors in Semprus BioSciences’ $18m series B round.
Pepsi drinks down One coconut
In a series B round of undisclosed size alongside consumer-focused private equity firm Catterton Partners, Pepsico increased its stake in One Natural Experience a year after first investing.
Phyzios downloads $5.6m
Phyzios, a Japan-based provider of applications for Apple’s iPhone, has raised $5.6m in its series B round.
MediaTek backs NetQin Mobile
MediaTek’s subsidiary, Gaintech, invested in NetQin , which has 64.8% of the Chinese mobile security market, according to consultants Frost & Sullivan.
Tabula Digital raises $2m
Pearson joined the consortium in Tabula’s $4.7m series C round in April, which was led by Intel Capital and included venture capital firm Ascend Venture Group.
Oak Pacific grows towards 2011 IPO
Newswire Reuters said Oak Pacific has hired investment banks Credit Suisse and Deutsche Bank for its initial public offering, five years after it had initially been mooted.
Isuzu eyes Swaraj deal drive
News provider Dealcurry said emerging markets private equity firm Actis was in talks with Isuzu about selling its 5.6% stake in Swaraj, as well as the further 6.7% owned by UK state-backed development company CDC.
Sumitomo digs into Molycorp shares
Sumitomo gains a seven-year guaranteed mineral supply contract from Molycorp after investment in rare earths mining company following China’s decision to limit exports to Japan following a diplomatic incident in the summer.
One97 postpones flotation
Strategic investors were set to help their Indian mobile services portfolio company One97 float to raise money to buy more telecoms equipment but after an initial deferment until mid-December, the initial public offering has been further delayed until next year.
Catabasis returns for second tranche
The $14.5m second tranche followed milestones towards clinical trials and came from MedImmune Ventures, a US-based corporate venturing unit of drugs company AstraZeneca, and venture capital firms SV Life Sciences, Advanced Technology Ventures and Clarus Ventures.
Venture market continues Chinese growth
The 10th China Venture Capital (VC) and Private Equity Annual Forum in Shanghai has found more than 850 attendees in a buoyant mood.
Sumitomo considers Molycorp stake
News provider Financial Times said Sumitomo’s was “considering a range of possibilities,” including an investment in mining company Molycorp.
BoSci avoids TyRx’s $20m round
Three venture capital firms rather than original backer Boston Scientific provide $20m for US-based medical equipment company TyRx.